CTSS and Hepatic fibrosis: Our recent study has identified cathepsin S upregulation as a central node of ECM remodeling in human fibrotic livers by proteomic screening and demonstrated cathepsin S as a potential target for the diagnosis and treatment of liver fibrosis by exploring its mechanism (9).